Long-Term Valproate Hematologic Side Effects

J Gordon Millichap

doi:10.15844/pedneurbriefs-8-1-4

Long-Term Valproate Hematologic Side Effects

Pediatric Neurology Briefs

Volume 8 (1994): Issue 1

By: J Gordon Millichap

Open Access

|Jan 1994

Abstract

Hematologic side effects in 60 patients, aged 2-29 years (mean 14 years), receiving valproate (VPA) monotherapy for >4 years in a long-term care facility, are reported from the Department of Pediatrics, East Carolina University School of Medicine, Greenville, North Carolina.

References

May RB Sunder TR Hematologic manifestations of long-term valproate therapy Epilepsia 1993 Nov-Dec 34 6 1098 1101 10.1111/j.1528-1157.1993.tb02139.x 8243362
Open DOI Search in Google Scholar Back to article

Articles in this issue

DOI: https://doi.org/10.15844/pedneurbriefs-8-1-4 | Journal eISSN: 2166-6482

Journal RSS Feed

Language: English

Page range: 3 - 3

Published on: Jan 1, 1994

Published by: Pediatric Neurology Briefs Publishers

In partnership with: Paradigm Publishing Services

Keywords:

Valproate,

Thrombocytopenia,

Hematologic Abnormalities

© 1994 J Gordon Millichap, published by Pediatric Neurology Briefs Publishers
This work is licensed under the Creative Commons Attribution 4.0 License.

Volume 8 (1994): Issue 1